Arista Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.44M Sell
5,570
-286
-5% -$337K 0.69% 25
2026
Q2
$7.02M Buy
5,856
+58
+1% +$59.3K 0.76% 23
2026
Q1
$5.33M Buy
5,798
+44
+0.8% +$44.6K 0.65% 28
2025
Q4
$6.18M Sell
5,754
-293
-5% -$280K 0.76% 21
2025
Q3
$4.61M Buy
6,047
+471
+8% +$350K 0.57% 25
2025
Q2
$4.35M Buy
+5,576
New +$4.33M 0.6% 25

Other funds holding LLY

Arista Wealth Management's LLY Position: Q3 2026 in Review

Arista Wealth Management reduced its Eli Lilly (LLY) stake by 4.9% in Q3 2026, selling an estimated $337K and leaving 5,570 shares worth $6.44M. The position accounts for 0.69% of the portfolio, ranked #25.

Arista Wealth Management first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $7.02M in Q2 2026. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Arista Wealth Management held 5,570 shares of Eli Lilly worth $6.44M as of Q3 2026.
  • Arista Wealth Management sold 286 Eli Lilly shares in Q3 2026, an estimated $337K.
  • Eli Lilly made up 0.69% of Arista Wealth Management's portfolio in Q3 2026, its #25 holding.
  • Arista Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • Arista Wealth Management's Eli Lilly position peaked at $7.02M in Q2 2026.
  • 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Arista Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.